|
1
|
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
|
N Engl J Med
|
2012
|
2.90
|
|
2
|
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
|
Blood
|
2011
|
2.44
|
|
3
|
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
|
J Neurol Neurosurg Psychiatry
|
2013
|
2.23
|
|
4
|
Diagnosis and management of calcified carotid artery atheroma: dental perspectives.
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
2.14
|
|
5
|
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
|
Neurology
|
2013
|
2.02
|
|
6
|
Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study.
|
Clin Drug Investig
|
2010
|
1.91
|
|
7
|
PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.
|
J Immunol
|
2009
|
1.79
|
|
8
|
Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
|
N Engl J Med
|
2009
|
1.63
|
|
9
|
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema.
|
J Bronchology Interv Pulmonol
|
2014
|
1.51
|
|
10
|
The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly.
|
J Allergy (Cairo)
|
2011
|
1.49
|
|
11
|
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
|
J Neurol Neurosurg Psychiatry
|
2012
|
1.41
|
|
12
|
Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy.
|
JAMA Neurol
|
2013
|
1.30
|
|
13
|
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
|
Mult Scler
|
2013
|
1.22
|
|
14
|
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.
|
J Hepatol
|
2003
|
1.17
|
|
15
|
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.
|
J Mol Med (Berl)
|
2010
|
1.13
|
|
16
|
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
|
Brain
|
2012
|
1.06
|
|
17
|
Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
|
Ther Adv Neurol Disord
|
2011
|
1.05
|
|
18
|
Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system.
|
J Neuropathol Exp Neurol
|
2002
|
1.02
|
|
19
|
Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
|
Muscle Nerve
|
2008
|
0.97
|
|
20
|
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.
|
J Med Genet
|
2013
|
0.96
|
|
21
|
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
|
Brain
|
2013
|
0.94
|
|
22
|
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
|
Ther Adv Neurol Disord
|
2012
|
0.93
|
|
23
|
alpha4-Integrin antagonism with natalizumab: effects and adverse effects.
|
J Neurol
|
2008
|
0.90
|
|
24
|
Allergic and nonallergic delayed infusion reactions during natalizumab therapy.
|
Arch Neurol
|
2008
|
0.90
|
|
25
|
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
|
Mult Scler
|
2010
|
0.89
|
|
26
|
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
|
Clin Cancer Res
|
2008
|
0.88
|
|
27
|
Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications.
|
J Neuroimmunol
|
2002
|
0.87
|
|
28
|
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
|
J Med Genet
|
2012
|
0.86
|
|
29
|
How can we improve the translational landscape for a faster cure of type 1 diabetes?
|
J Clin Invest
|
2009
|
0.84
|
|
30
|
PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.
|
Mol Neurodegener
|
2011
|
0.84
|
|
31
|
Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.
|
Inflamm Bowel Dis
|
2014
|
0.83
|
|
32
|
Bronchiolitis obliterans.
|
Clin Rev Allergy Immunol
|
2003
|
0.83
|
|
33
|
Anti-inflammatory effects of the anticonvulsant drug levetiracetam on electrophysiological properties of astroglia are mediated via TGFβ1 regulation.
|
Br J Pharmacol
|
2011
|
0.82
|
|
34
|
Differential expression of BDNF mRNA splice variants in mouse brain and immune cells.
|
J Neuroimmunol
|
2006
|
0.82
|
|
35
|
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease.
|
J Neurol
|
2007
|
0.82
|
|
36
|
Thoracic manifestations of common nonpulmonary malignancies of women.
|
Clin Chest Med
|
2004
|
0.81
|
|
37
|
Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
|
Mod Pathol
|
2002
|
0.81
|
|
38
|
Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions.
|
J Neuropathol Exp Neurol
|
2007
|
0.81
|
|
39
|
Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis.
|
J Neurol
|
2007
|
0.80
|
|
40
|
Immunomodulation and postpartum relapses in patients with multiple sclerosis.
|
Ther Adv Neurol Disord
|
2009
|
0.80
|
|
41
|
Translational research in neurology and neuroscience 2010: multiple sclerosis.
|
Arch Neurol
|
2010
|
0.79
|
|
42
|
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
|
J Neurol Sci
|
2011
|
0.79
|
|
43
|
1H-magnetic resonance spectroscopy in diffuse and focal cervical cord lesions in multiple sclerosis.
|
Eur Radiol
|
2013
|
0.79
|
|
44
|
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
|
Neurogenetics
|
2014
|
0.79
|
|
45
|
Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients.
|
Mol Cell Probes
|
2011
|
0.78
|
|
46
|
Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.
|
PLoS One
|
2011
|
0.78
|
|
47
|
SPR1. An early molecular marker for bronchial carcinogenesis.
|
Methods Mol Med
|
2003
|
0.78
|
|
48
|
Obstructive sarcoidosis.
|
Clin Rev Allergy Immunol
|
2003
|
0.77
|
|
49
|
The role of aspirin in colorectal cancer prevention and treatment.
|
Oncology (Williston Park)
|
2013
|
0.77
|
|
50
|
Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
|
Mult Scler
|
2012
|
0.77
|
|
51
|
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample.
|
Neurogenetics
|
2011
|
0.77
|
|
52
|
Single-detector helical CT in PET-CT: assessment of image quality.
|
AJR Am J Roentgenol
|
2004
|
0.77
|
|
53
|
Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
|
Radiother Oncol
|
2009
|
0.76
|
|
54
|
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
|
Ther Adv Neurol Disord
|
2013
|
0.76
|
|
55
|
Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology.
|
J Neurol
|
2008
|
0.75
|
|
56
|
In reply.
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2013
|
0.75
|
|
57
|
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
|
Neurology
|
2012
|
0.75
|
|
58
|
Therapeutic monitoring of immunotherapies in autoimmune diseases.
|
Curr Pharm Des
|
2012
|
0.75
|
|
59
|
Covering the Cover.
|
Gastroenterology
|
2017
|
0.75
|
|
60
|
Stability of Cohen-Grossberg neural networks with time-varying delays.
|
Neural Netw
|
2007
|
0.75
|
|
61
|
Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters.
|
Acta Derm Venereol
|
2012
|
0.75
|
|
62
|
Anti-JC-virus antibody prevalence in a German MS cohort.
|
Mult Scler
|
2012
|
0.75
|
|
63
|
Unusual dyspnea in a woman with CREST syndrome.
|
Chest
|
2008
|
0.75
|
|
64
|
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
|
J Med Econ
|
2013
|
0.75
|
|
65
|
A pregnant woman with headaches, seizures, and hypertension.
|
Lancet
|
2005
|
0.75
|
|
66
|
No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
|
Arch Neurol
|
2011
|
0.75
|
|
67
|
OTC Secondary Prevention of Metastatic Colorectal Cancer Moves Closer to Clinical Reality.
|
Oncology (Williston Park)
|
2015
|
0.75
|